This most current twist while in the Lykos Therapeutics saga threatens A significant overhaul of the company’s system and direction, with Musk ally and billionaire investor Antonio Gracias showing up to choose to acquire the business back again toward its nonprofit drug enhancement roots and a more Doblinite philosophy.“This could have transpir